ELAFIBRANOR for Primary biliary cholangitis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 288 adverse event reports in the FDA FAERS database where ELAFIBRANOR was used for Primary biliary cholangitis.
Most Reported Side Effects for ELAFIBRANOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 45 | 12.6% | 0 | 1 |
| Pruritus | 34 | 9.6% | 0 | 0 |
| Constipation | 33 | 9.3% | 0 | 2 |
| Nausea | 30 | 8.4% | 0 | 1 |
| Product dose omission issue | 27 | 7.6% | 1 | 5 |
| Weight increased | 26 | 7.3% | 0 | 0 |
| Myalgia | 25 | 7.0% | 0 | 0 |
| Diarrhoea | 24 | 6.7% | 0 | 3 |
| Arthralgia | 21 | 5.9% | 0 | 0 |
| Dizziness | 17 | 4.8% | 1 | 2 |
| Muscle spasms | 16 | 4.5% | 0 | 0 |
| Headache | 15 | 4.2% | 0 | 0 |
| Vomiting | 15 | 4.2% | 0 | 1 |
| Abdominal distension | 13 | 3.7% | 0 | 0 |
| Abdominal pain | 13 | 3.7% | 0 | 0 |
Other Indications for ELAFIBRANOR
Other Drugs Used for Primary biliary cholangitis
OBETICHOLIC ACID (4,838)
URSODIOL (203)
FENOFIBRATE (40)
SELADELPAR LYSINE (39)
SELADELPAR (36)
AZATHIOPRINE (14)
BEZAFIBRATE (13)
PREDNISONE (11)
RITUXIMAB (11)
BUDESONIDE (8)